<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00988663</url>
  </required_header>
  <id_info>
    <org_study_id>Memantine ECT trial</org_study_id>
    <nct_id>NCT00988663</nct_id>
  </id_info>
  <brief_title>The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems?</brief_title>
  <acronym>ECTAug</acronym>
  <official_title>Memantine Augmentation of Electroconvulsive Therapy in Patients With Major Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jerrry L Lewis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether memantine will enhance the therapeutic of
      effect on depression and prevent memory and other cognitive problems caused by ECT.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be assigned randomly either to a treatment group or a placebo groups. All
      patients in both groups will be receiving standard ECT. The treatment group will receive
      memantine. All patients will be given a battery of cognitive tests and test of depression
      before ECT treatments start, after the 6th ECT treatment and after the completions of ECT. An
      analysis will be performed to see if memantine causes any impact on the response to ECT and
      prevents memory and cognitive impairment.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    PI deceased; study did not start.
  </why_stopped>
  <start_date type="Actual">November 2009</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of whether Memantine protects memory and cognitive impairment caused by ECT.</measure>
    <time_frame>6 to 8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Whether memantine will improve response of Depression to Electroconvulsive therapy.</measure>
    <time_frame>6-8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Memantine arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient receiving ECT and Memantine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>25 patients receiving ECT will will receive placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>memantine</intervention_name>
    <description>patient will receive 5mg daily for 7day then 10 mgm daily</description>
    <arm_group_label>Memantine arm</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
    <other_name>Namenda</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>will give placebo that looks like memantine</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meets criteria for Major Depressive disorder

        Exclusion Criteria:

          -  Neurological disease

          -  Mental retardation

          -  Seizure disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerry L Lewis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa Hospitals and Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Iowa hosptitals and clinic</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>50208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2009</study_first_submitted>
  <study_first_submitted_qc>October 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2009</study_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Jerrry L Lewis</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>electroconvulsive therapy</keyword>
  <keyword>memantine</keyword>
  <keyword>cognitive function</keyword>
  <keyword>memory</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Memantine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

